These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

726 related items for PubMed ID: 21460309

  • 1. Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets.
    Kullar R, Davis SL, Levine DP, Rybak MJ.
    Clin Infect Dis; 2011 Apr 15; 52(8):975-81. PubMed ID: 21460309
    [Abstract] [Full Text] [Related]

  • 2. Area under the concentration-time curve to minimum inhibitory concentration ratio as a predictor of vancomycin treatment outcome in methicillin-resistant Staphylococcus aureus bacteraemia.
    Jung Y, Song KH, Cho Je, Kim HS, Kim NH, Kim TS, Choe PG, Chung JY, Park WB, Bang JH, Kim ES, Park KU, Park SW, Kim HB, Kim NJ, Oh MD.
    Int J Antimicrob Agents; 2014 Feb 15; 43(2):179-83. PubMed ID: 24315788
    [Abstract] [Full Text] [Related]

  • 3. Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia.
    Khatib R, Jose J, Musta A, Sharma M, Fakih MG, Johnson LB, Riederer K, Shemes S.
    J Antimicrob Chemother; 2011 Jul 15; 66(7):1594-9. PubMed ID: 21525024
    [Abstract] [Full Text] [Related]

  • 4. Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin.
    Yoon YK, Kim JY, Park DW, Sohn JW, Kim MJ.
    J Antimicrob Chemother; 2010 May 15; 65(5):1015-8. PubMed ID: 20200036
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Relationships between vancomycin minimum inhibitory concentration, dosing strategies, and outcomes in methicillin-resistant Staphylococcus aureus bacteremia.
    Clemens EC, Chan JD, Lynch JB, Dellit TH.
    Diagn Microbiol Infect Dis; 2011 Dec 15; 71(4):408-14. PubMed ID: 21924852
    [Abstract] [Full Text] [Related]

  • 10. A stewardship program's retrospective evaluation of vancomycin AUC24/MIC and time to microbiological clearance in patients with methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.
    Gawronski KM, Goff DA, Brown J, Khadem TM, Bauer KA.
    Clin Ther; 2013 Jun 15; 35(6):772-9. PubMed ID: 23795575
    [Abstract] [Full Text] [Related]

  • 11. [Evaluation of pharmacodynamic target attainment with vancomycin treatment of bacteremia due to Staphylococcus aureus methicillin resistant].
    Lepe JA, Gil-Navarro MV, Santos-Rubio MD, Bautista J, Aznar J.
    Rev Esp Quimioter; 2010 Mar 15; 23(1):43-7. PubMed ID: 20232023
    [Abstract] [Full Text] [Related]

  • 12. Impact of source of infection and vancomycin AUC0-24/MICBMD targets on treatment failure in patients with methicillin-resistant Staphylococcus aureus bacteraemia.
    Ghosh N, Chavada R, Maley M, van Hal SJ.
    Clin Microbiol Infect; 2014 Dec 15; 20(12):O1098-105. PubMed ID: 24890030
    [Abstract] [Full Text] [Related]

  • 13. Predicting high vancomycin minimum inhibitory concentration isolate infection among patients with community-onset methicillin-resistant Staphylococcus aureus bacteraemia.
    Chen SY, Hsueh PR, Chiang WC, Huang EP, Lin CF, Chang CH, Chen SC, Chen WJ, Chang SC, Lai MS, Chie WC.
    J Infect; 2014 Sep 15; 69(3):259-65. PubMed ID: 24797078
    [Abstract] [Full Text] [Related]

  • 14. Vancomycin MICs do not predict the outcome of methicillin-resistant Staphylococcus aureus bloodstream infections in correctly treated patients.
    Rojas L, Bunsow E, Muñoz P, Cercenado E, Rodríguez-Créixems M, Bouza E.
    J Antimicrob Chemother; 2012 Jul 15; 67(7):1760-8. PubMed ID: 22556382
    [Abstract] [Full Text] [Related]

  • 15. Influence of teicoplanin MICs on treatment outcomes among patients with teicoplanin-treated methicillin-resistant Staphylococcus aureus bacteraemia: a hospital-based retrospective study.
    Chang HJ, Hsu PC, Yang CC, Siu LK, Kuo AJ, Chia JH, Wu TL, Huang CT, Lee MH.
    J Antimicrob Chemother; 2012 Mar 15; 67(3):736-41. PubMed ID: 22169187
    [Abstract] [Full Text] [Related]

  • 16. Clinical, microbiologic, and genetic determinants of persistent methicillin-resistant Staphylococcus aureus bacteremia.
    Neuner EA, Casabar E, Reichley R, McKinnon PS.
    Diagn Microbiol Infect Dis; 2010 Jul 15; 67(3):228-33. PubMed ID: 20542203
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.